The Triggle effect

Simple item page
dc.contributor.authorSnutch, Terrance Preston
dc.contributor.authorZamponi, Gerald W.
dc.date.accessioned2018-05-30T15:49:47Z
dc.date.available2018-05-30T15:49:47Z
dc.date.issued2015-07-20
dc.description.abstractDr. David Triggle is considered a pioneer in the area of ion channel pharmacology. Over the course of his career, he made a number of particularly important contributions to our understanding of dihydropyridine interactions with L-type calcium channels. He also contributed his highly sought after expertise towards the drug discovery platform of the Canadian biopharmaceutical company, NeuroMed Pharmaceuticals (subsequently Zalicus). Here we briefly highlight his contributions to the field of calcium channel pharmacology, and then provide examples of his impact on NeuroMed.en_US
dc.identifier.citationSnutch, T. P., & Zamponi, G. W. (2015, June 15). The Triggle effect. Biochemical Pharmacology. Elsevier Inc. https://doi.org/10.1016/j.bcp.2015.07.003en_US
dc.identifier.doihttp://dx.doi.org/10.1016/j.bcp.2015.07.003en_US
dc.identifier.urihttp://hdl.handle.net/1880/106713
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.publisher.departmentPhysiology & Pharmacologyen_US
dc.publisher.facultyCumming School of Medicineen_US
dc.publisher.institutionUniversity of Calgaryen_US
dc.publisher.policyhttps://www.elsevier.com/about/our-business/policies/sharingen_US
dc.rights.urihttps://creativecommons.org/licenses/by/4.0en_US
dc.titleThe Triggle effecten_US
dc.typejournal articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Triggle effect Zamponi Snutch, 2015.pdf
Size:
801.87 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.92 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Cumming School of Medicine Research & Publications